AMREPEG Trademark

Trademark Overview


On Tuesday, November 19, 2019, a trademark application was filed for AMREPEG with the United States Patent and Trademark Office. The USPTO has given the AMREPEG trademark a serial number of 88698655. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 3, 2023. This trademark is owned by Eli Lilly and Company. The AMREPEG trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, neurodegenerative diseases and disorders, neurological disorders, obesity, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis
amrepeg

General Information


Serial Number88698655
Word MarkAMREPEG
Filing DateTuesday, November 19, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 3, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 7, 2020

Trademark Statements


Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, neurodegenerative diseases and disorders, neurological disorders, obesity, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, November 26, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEli Lilly and Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Party NameEli Lilly and Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Trademark Events


Event DateEvent Description
Monday, July 3, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, July 3, 2023ABANDONMENT - NO USE STATEMENT FILED
Tuesday, November 15, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 14, 2022SOU EXTENSION 5 GRANTED
Wednesday, November 9, 2022SOU EXTENSION 5 FILED
Wednesday, November 9, 2022TEAS EXTENSION RECEIVED
Friday, May 20, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 18, 2022SOU EXTENSION 4 GRANTED
Wednesday, May 18, 2022SOU EXTENSION 4 FILED
Wednesday, May 18, 2022TEAS EXTENSION RECEIVED
Wednesday, October 13, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 12, 2021SOU EXTENSION 3 GRANTED
Thursday, October 7, 2021SOU EXTENSION 3 FILED
Thursday, October 7, 2021TEAS EXTENSION RECEIVED
Wednesday, May 19, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 17, 2021SOU EXTENSION 2 GRANTED
Monday, May 17, 2021SOU EXTENSION 2 FILED
Monday, May 17, 2021TEAS EXTENSION RECEIVED
Saturday, December 12, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 11, 2020SOU EXTENSION 1 GRANTED
Monday, November 16, 2020SOU EXTENSION 1 FILED
Monday, November 30, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, November 16, 2020TEAS EXTENSION RECEIVED
Tuesday, June 2, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 7, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 7, 2020PUBLISHED FOR OPPOSITION
Wednesday, March 18, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sunday, March 1, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Sunday, February 23, 2020ASSIGNED TO EXAMINER
Tuesday, November 26, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, November 22, 2019NEW APPLICATION ENTERED